BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 17, 2008
View Archived Issues
Amgen presents results from a phase II study of AMG-108 in RA patients
Read More
Trial data show beneficial effects of epratuzumab in systemic lupus erythematosus
Read More
Atrasentan-liposomal doxorubicin combination feasible in platinum-resistant ovarian cancer
Read More
Nanocort safe in rheumatoid arthritis patients
Read More
ITF-2357 affects disease activity in systemic onset juvenile idiopathic arthritis
Read More
Esreboxetine improves pain, function and fatigue in double-blind fibromyalgia study
Read More
Athersys achieves development milestone in Bristol-Myers discovery alliance
Read More
Duska and DSM enter manufacturing collaboration for ATPace
Read More
Medtronic acquires CryoCath Technologies
Read More
Clinical data on CP-690550 in rheumatoid arthritis accumulates
Read More
AMG-623 characterized in phase I studies in systemic lupus erythematosus patients
Read More
FDA accepts TheraQuest's IND for abuse deterrent opioid TQ-1015
Read More
Novel compounds for lipoprotein disorders described in recent patents
Read More
Genetic Immunity doses first patient in phase II DermaVir Patch trial for HIV
Read More
Sygnis receives European orphan drug status for AX-200 in spinal cord injury
Read More
New antidiabetic agents disclosed in recent patent literature
Read More
GSK and Janssen patents divulge new therapeutics for GI disorders
Read More
Recent patent literature reports new oncolytic agents
Read More
Daiichi Sankyo commences phase III anti-influenza CS-8958 trial
Read More
FDA approves Banzel as adjunctive treatment for Lennox-Gastaut syndrome
Read More
Vernalis presents an update on clinical activities between July and November 2008
Read More
Third quarter highlights at AEterna Zentaris
Read More
Pfizer launches independent research unit Pfizer Regenerative Medicine
Read More
New glycine transporter GlyT1 inhibitor profiled at Merck & Co.
Read More
Merck Eprova imparts new PET imaging agents in recent patents
Read More
